We tested the ability of in vitro treatment of human melanoma cells with hIFN-γ and GGTI-298 to enhance membrane MHC-I expression, and in particular the MHC-I allele able to present an immunodominant TAA peptide. This evidence concerns the gene PGGT1B and melanoma.